possible and, in fact, likely that j&j recipients will need a boost. but the question is, at what time frame and also, with what vaccine? a j&j vaccine or an mrna vaccine. we re awaiting data from johnson & johnson, the company itself, about a two-dose regiment of j&j that will help us understand the safety and efficacy of the second dose. and we have what are called mixing studies under way, where you get one type of vaccine and another vaccine, including j&j and mrna mix so we can look at the effectiveness of that combination. and we ll make sure that data is evaluated and we ll get that recommendation with the recommendation to j&j recipients. we do not want anyone left behind regardless of what vaccine you got, that s why all three are going to be our priority. as you know better than